Onabotulinumtoxin a injections for patients with pelvic floor dysfunction

G Whitmore,J Tam,M Orlando
DOI: https://doi.org/10.1016/j.ajog.2024.02.279
IF: 9.8
2024-03-21
American Journal of Obstetrics and Gynecology
Abstract:It is estimated that about 50-90% of patients with chronic pelvic pain have pain that originates from myofascial sources, including the pelvic floor muscles. In patients with pelvic floor dysfunction, we generally recommend that patients start with pelvic floor physical therapy alone or in combination with pelvic trigger point injections with local anesthetic. We offer onabotulinum toxin A to those who require long-term repeat trigger point injections, have barriers to accessing monthly injections, or feel that their symptom relief has plateaued. Onabotulinumtoxin A blocks peripheral acetylcholine receptors from presynaptic neurons, resulting in muscle relaxation. It also helps with centralized pain by blocking neurotransmitters involved in pain perception. Adverse effects may include bruising, hematoma, constipation, urinary retention, urinary tract infections, urinary, flatulence, or bowel incontinence. Medication effects can last up to 3-6 months and it is important to review potential benefits, risks, and side effects.
obstetrics & gynecology
What problem does this paper attempt to address?